Compare BOH & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOH | PBH |
|---|---|---|
| Founded | 1897 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | N/A | 2005 |
| Metric | BOH | PBH |
|---|---|---|
| Price | $69.03 | $61.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $72.00 | ★ $86.40 |
| AVG Volume (30 Days) | 352.3K | ★ 429.1K |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 22.78 | N/A |
| EPS | ★ 4.09 | 4.04 |
| Revenue | $677,459,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $15.10 | N/A |
| Revenue Next Year | $8.26 | $2.50 |
| P/E Ratio | $16.99 | ★ $15.19 |
| Revenue Growth | ★ 8.56 | N/A |
| 52 Week Low | $57.45 | $57.25 |
| 52 Week High | $76.25 | $90.04 |
| Indicator | BOH | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | 56.45 |
| Support Level | $67.29 | $59.52 |
| Resistance Level | $70.58 | $62.14 |
| Average True Range (ATR) | 1.29 | 1.55 |
| MACD | 0.38 | 0.32 |
| Stochastic Oscillator | 76.73 | 86.90 |
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.